Newsroom
News from UCLB
UCLTF’s Simon Goldman and David Grimm make the Top 25 of the GUV Powerlist 2018
Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by ...
£438 million investment for UCL gene therapy spinouts
UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene ...
UCLB spinout Orchard Therapeutics announces closing of $225 million Initial Public Offering
UCLB spinout Orchard Therapeutics, a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases ...
Orchard Therapeutics announces pricing of its initial public offering
UCLB spinout Orchard Therapeutics has announced the pricing of its initial public offering in the United States of 14,285,715 American ...
UCLB spinout Endomag wins the prestigious British Business Innovation Award from the Institute of Physics
UCLB spinout Endomag, the surgical guidance company, has won a prestigious British Business Innovation Award from the Institute of Physics ...
Global University Venturing Interviews UCLTF’s David Grimm
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the ...
Announcing Cengiz Tarhan’s retirement from UCLB
Having spent 30 years at UCL, 25 of those at UCLB, Cengiz Tarhan announces his intention to retire, stepping down ...
UCLB Spinout Orchard Therapeutics Proposes to Raise up to $172.5 million in an IPO
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative ...
UCLB launches new logo and branding
Today we are pleased to launch our new logo and branding. This new look will take UCLB on to the ...
UCLB Spinout Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative ...
Recent coverage of UCLB spinout Hazy’s extra $1.8m in seed funding, led by UCL Technology Fund
Data anonymisation software developer, Hazy gained coverage in The Telegraph’s Technology Intelligence pages, in light of the $1.8m it has ...
Endomagnetics Ltd secures $10m (£8m) funding to establish better breast cancer care
UCLB spinout company, Endomagnetics Ltd, who are developing a portfolio of products to improve the standard of breast cancer management, ...
UCLB Toasts 25 Years of UCL Innovation at its Annual Summer Reception
Thursday the 5th July saw UCLB host its annual summer reception event, celebrating some of the remarkable achievements of the ...
£265 million investment in UCL spin-outs which could transform patient outcomes
Three UCL spin-out companies focused on delivering advanced therapeutics to treat a range of diseases received a substantial amount of ...
UCL computer vision spin-out acquired by Niantic Inc.
UCL spin-out Matrix Mill Ltd, a company specialising in applying artificial intelligence and machine vision research to solve industry problems, ...
